Related Experiment Videos
[Legionnaires' disease]
1First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus.
Abstract:
Among community-acquired pneumonias or hospital-acquired pneumonias, the genus Legionella, an intracellular bacteria, is one of the most important pathogens causing death. The bacteria from clinical specimens could not be cultured by ordinary methods and the polymerase chain reaction, a new method for rapid detection, has been developed; however, Legionella pneumonias are still difficult to diagnose. Antibiotics, such as macrolides, new quinolones and rifampicin, are very active against Legionella spp. These antibacterial agents should be administered when acute pneumonia tends to exacerbate with previous beta-lactams or aminoglycosides therapy. Legionella pneumonias are more likely to occur in elderly males or in the compromised-hosts with underlying diseases, such as malignancy, diabetes mellitus, AIDS, etc.
Insights
Legionella bacteria cause severe pneumonia and are hard to diagnose. Effective antibiotics like macrolides and quinolones are crucial for treating Legionella infections, especially in vulnerable patients.
Area of Science:
- Microbiology
- Infectious Diseases
Context:
- Legionella species are significant intracellular bacterial pathogens responsible for community-acquired and hospital-acquired pneumonias.
- Traditional culture methods for Legionella from clinical samples are often unsuccessful, complicating diagnosis.
Purpose:
- To highlight the diagnostic challenges associated with Legionella pneumonia.
- To discuss effective antibiotic therapies and patient risk factors.
Summary:
- Legionella pneumonia remains difficult to diagnose despite the development of rapid detection methods like polymerase chain reaction (PCR).
- Antibiotics including macrolides, new quinolones, and rifampicin show high activity against Legionella.
- Treatment with these agents is recommended for pneumonia exacerbations, particularly after beta-lactam or aminoglycoside therapy.
Impact:
- Early and accurate diagnosis of Legionella pneumonia is critical for timely and effective treatment.
- Understanding risk factors, such as advanced age, male gender, and compromised immune status, aids in identifying high-risk individuals.
- Appropriate antibiotic selection can improve patient outcomes and reduce mortality associated with Legionella infections.